Skip to content

CiNPT for Abdominoplasties in Post-bariatric Patients Study

Evaluation of ciNPT Effects on Healing and Post-surgical Complications in High-risk Post- Bariatric Patients Undergoing Body-contouring Abdominoplasty: a Monocentric Prospective RCT

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04214236
Acronym
CAPS
Enrollment
130
Registered
2020-01-02
Start date
2020-02-01
Completion date
2023-01-31
Last updated
2020-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incision, Incision Site Bleeding, Incision Site Complication, Incision Site Haematoma, Incision Site Infection, Incision Site Inflammation, Incision Site Rash, Incision Site Swelling, Incision Surgical, Obesity, Obesity, Abdominal, Obesity, Morbid, Scar, Scarring, Scarring as Surgical Complication, Surgery--Complications, Surgical Site Infection, Surgical Wound Infection, Wound, Wound; Abdomen, Wound Complication, Wound Contamination, Wound Dehiscence, Wound Heal, Wound Infection

Keywords

Closed-incision negative pressure therapy, Negative pressure wound therapy, Wound care, Surgical incision, Wound complication, Dehiscence, Surgical Site Infection, Seroma, Hematoma, Wound Healing, Inflammation, Incisional Wound, Abdominoplasty, Abdominal panniculectomy, Body contouring

Brief summary

The overarching goal of this research is to assess whether the post-operative use of closed-incision Negative Pressure Therapy (ciNPT) accelerates healing of surgical wounds, improves surgical outcomes, and reduces the rate of local complications in high-risk, obese, post-bariatric patients undergoing abdominal body-contouring procedures (abdominal panniculectomy or abdominoplasty) compared to standard wound care. The investigators postulate that ciNPT can cost-effectively improve outcomes and standard of post-surgical care in this specific category of patients. This hypothesis will be tested through a prospective, interventional, case-control, randomized clinical trial.

Detailed description

In the United States (US) 37% of the adult population is obese and 5% is considered morbidly obese. Similar trends have been observed in Europe and more recently in Asia. A large number of obese patients seeks treatment through bariatric surgery or diet-lifestyle changes. The resulting massive loss of weight leaves patients with an excess cutaneous tissue, requiring body-contouring procedures. In the US 85% of post-bariatric patients seek body-contouring surgeries. Due to systemic and local factors, these procedures show a rate of local complications as high as 68-80%, significantly prolonging hospitalization and increasing treatment-related costs. Several clinical studies have shown that external suction (Closed Incision Negative-Pressure Therapy, ciNPT) can accelerate closure of surgical wounds in patients at high-risk for impaired/delayed healing and can significantly reduce the rate of local complications. The investigators believe that ciNPT might significantly decrease the rate of minor local complications in post-bariatric patients undergoing body-contouring procedures, and that this strategy could represent a cost-effective adjuvant treatment in body-contouring procedures. The investigators' preliminary study experience on post-bariatric obese patients undergoing an abdominoplasty and post-operatively treated with ciNPT, showed that ciNPT promotes effective and prompt wound closure minimizing peri-operative/post-operative complications in these patients. The investigators also showed that ciPNT positively impacts the length of hospitalization and the rate of secondary surgeries in these patients. Based on this successful preliminary experience, the invetsigators here propose to validate these findings in a prospective RCT.

Interventions

DEVICEciNPT group

Closed-incision negative pressure therapy (ciNPT) will be applied for 7 day using continuous suction at 125 mmHg. To deliver ciNPT we will use a commercially available, FDA-approved device, used according to the manufacturer' indications (PREVENA™ Incision Management System (KCI, San Antonio, Texas, USA). After the first 7 post-operative days, subjects will discontinue the ciNPT and follow a standard wound care protocol.

OTHERControl group

Standard non-adherent surgical dressing (Vaseline petrolatum gauze) will be used for management of incisional wounds in the control group. Dressing changes will be performed per standard wound care protocol.

Sponsors

Acelity
CollaboratorOTHER
Azienda Ospedaliera, Ospedale Civile di Legnano
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

Analysis of data and statistical analysis will be blinded to groups.

Intervention model description

Case-control Experimental/Interventional Group: post-operative ciNPT (first 7 days) Control Group: post-operative standard wound care

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* previous bariatric surgery for weight loss * candidate for/undergoing an abdominal panniculectomy (abdominoplasty) * Residual BMI \>30 kg/m2 at the time of the operation * Evidence of pannus (abdominal) ptosis (Pittsburgh Rating Scale \>2) * Lipodystrophy and inelasticity of the skin * Presence at the time of surgery of at least one local risk factor (e.g. a history or the presence of local complications such as skin blistering, recurrent erythema, panniculitis, or chronic infection; history of abdominal hernia or need for abdominal hernia repair) OR one systemic risk factor (diabetes, smoking habit, serum proteins below 6g/dL).

Exclusion criteria

* Severe systemic co-morbidities (defined as ASA III or higher) * Malignant tumors * Conditions or medications affecting wound healing (e.g. steroidal drugs or keloids) * Known allergies to components of the treatment * Presence of severe local cutaneous complications (open wounds, extensive infections) at the time of surgery.

Design outcomes

Primary

MeasureTime frameDescription
Rate of post-surgical local complications30 daysThe change in post-surgical local complications (Skin blistering/necrosis, Surgical Site Infections, hematoma, seroma, need for re-operation) through 30 days after surgery.

Secondary

MeasureTime frameDescription
Time-to-heal<60 daysA change in time (days) to complete wound closure for treated groups vs. controls.
Scar quality: Vancouver Scar Scale30 and 90 daysA change in the macroscopic quality of scars at a 30 and 90 days follow up (measured with the Vancouver Scar Scale-VSS \[Score range: 0-13, lower scores being a better outcome\]).
Medical costs60 daysA change in direct medical costs (considering cumulative costs related to: hospitalization, standard and additional post-operative care, additional surgical and medical care for complications) in the first 60 days after surgery.

Contacts

Primary ContactSilvio Abatangelo, M.D.
caps.trial@gmail.com+39 (02) 97 96 3466

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026